myRAteam

Early research shows promising results for stem cell therapy in treating rheumatoid arthritis, particularly using mesenchymal stem cells (MSCs). Laboratory studies have demonstrated that MSCs can suppress immune cell activity and decrease inflammation-causing chemicals while increasing anti-inflammatory responses in RA Show Full Answer

Early research shows promising results for stem cell therapy in treating rheumatoid arthritis, particularly using mesenchymal stem cells (MSCs). Laboratory studies have demonstrated that MSCs can suppress immune cell activity and decrease inflammation-causing chemicals while increasing anti-inflammatory responses in RA patients.

Studies using MSCs have shown improvements in RA symptoms, including reduced bone erosion and joint inflammation. Initial clinical studies using umbilical cord blood-derived MSCs found no negative side effects and showed decreased levels of inflammatory markers. A 2022 clinical trial tested MSCs derived from fat tissue in RA patients. After a single treatment, participants experienced improvements in joint pain and swelling that lasted through one year of follow-up. While these results are encouraging, larger clinical trials with placebo controls are still needed to confirm the treatment's effectiveness.

It's important to note that stem cell therapy is not currently FDA approved for RA treatment. Anyone considering this option should consult with their rheumatologist and only pursue FDA-approved or studied therapies to ensure safety.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Stem Cell Therapy for Rheumatoid Arthritis: Safety and More